“These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential,” says the author of today’s article of the five Buy-rated stocks trading under $10 that he highlights. For these five stocks – which include a clinical-stage pharmaceutical company focused on the development of novel therapies for the treatment of serious and life-threatening rare respiratory diseases – CLICK HERE.
5 Stocks Under $10 Offering Solid Alpha Potential For Aggressive Investors
![](https://www.zenectwealth.com/wp-content/uploads/2021/03/2021-03-21-20_40_02-Cutout-paper-composition-of-human-and-money-under-dome-·-Free-Stock-Photo.png)
Tags:Aggressive InvestorsAlpha PotentialBuy-Rated StocksClinical-Stage Pharmaceutical Investmentsstock marketstocksStocks Under $10Upside Potential